|
|
||||||||
J Biol Chem, Vol. 274, Issue 26, 18702-18708, June 25, 1999
From the Department of Pathology, Washington University School of
Medicine, St. Louis, Missouri 63110
Recent studies have identified a
Tumor Necrosis Factor
-induced Pancreatic
-Cell Insulin
Resistance Is Mediated by Nitric Oxide and Prevented by
15-Deoxy-
12,14-prostaglandin J2 and
Aminoguanidine
A ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR
ACTIVATION AND iNOS EXPRESSION
-cell insulin
receptor that functions in the regulation of protein translation and
mitogenic signaling similar to that described for insulin-sensitive
cells. These findings have raised the novel possibility that
-cells may exhibit insulin resistance similar to skeletal muscle, liver, and
fat. To test this hypothesis, the effects of tumor necrosis factor-
(TNF
), a cytokine proposed to mediate insulin resistance by
interfering with insulin signaling at the level of the insulin receptor
and its substrates, was evaluated. TNF
inhibited
p70s6k activation by glucose-stimulated
-cells of
the islets of Langerhans in a dose- and time-dependent
manner, with maximal inhibition observed at ~20-50 ng/ml, detected
after 24 and 48 h of exposure. Exogenous insulin failed to prevent
TNF
-induced inhibition of p70s6k, suggesting
a defect in the insulin signaling pathway. To further define mechanisms
responsible for this inhibition and also to exclude cytokine-induced
nitric oxide (NO) as a mediator, the ability of exogenous or endogenous
insulin ± inhibitors of nitric-oxide synthase (NOS) activity,
aminoguanidine or N-monomethyl-L-arginine, was
evaluated. Unexpectedly, TNF
and also interleukin 1 (IL-1)-induced inhibition of p70s6k was completely prevented by inhibitors
that block NO production. Western blot analysis verified inducible NOS
(iNOS) expression after TNF
exposure. Furthermore, the ability of
IL-1 receptor antagonist protein, IRAP, to block TNF
-induced
inhibition of p70s6k indicated that activation of
intra-islet macrophages and the release of IL-1 that induces iNOS
expression in
-cells was responsible for the inhibitory effects of
TNF
. This mechanism was confirmed by the ability of the peroxisome
proliferator-activated receptor-
agonist
15-deoxy-
12,14-prostaglandin J2 to attenuate
TNF
-induced insulin resistance by down-regulating iNOS expression
and/or blocking IL-1 release from activated macrophages. Overall,
TNF
-mediated insulin resistance in
-cells is characterized by a
global inhibition of metabolism mediated by NO differing from that
proposed for this proinflammatory cytokine in insulin-sensitive cells.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-R. Liu, L. Tao, E. Gao, Y. Qu, W. B. Lau, B. L. Lopez, T. A. Christopher, W. Koch, T.-L. Yue, and X.-L. Ma Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists Cardiovasc Res, December 4, 2008; (2008) cvn308v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Weiss, A. M. Cali, J. Dziura, T. S. Burgert, W. V. Tamborlane, and S. Caprio Degree of Obesity and Glucose Allostasis Are Major Effectors of Glucose Tolerance Dynamics in Obese Youth Diabetes Care, July 1, 2007; 30(7): 1845 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pietropaolo, E. Barinas-Mitchell, and L. H. Kuller The Heterogeneity of Diabetes: Unraveling a Dispute: Is Systemic Inflammation Related to Islet Autoimmunity? Diabetes, May 1, 2007; 56(5): 1189 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carvalho-Filho, M. Ueno, S. M. Hirabara, A. B. Seabra, J. B.C. Carvalheira, M. G. de Oliveira, L. A. Velloso, R. Curi, and M. J.A. Saad S-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt: A Novel Mechanism of Insulin Resistance Diabetes, April 1, 2005; 54(4): 959 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Emanuelli, M. Glondu, C. Filloux, P. Peraldi, and E. Van Obberghen The Potential Role of SOCS-3 in the Interleukin-1{beta}-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells Diabetes, December 1, 2004; 53(suppl_3): S97 - S103. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Sanchez-Gomez, E. Cernuda-Morollon, K. Stamatakis, and D. Perez-Sala Protein Thiol Modification by 15-deoxy-{Delta}12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes Mol. Pharmacol., November 1, 2004; 66(5): 1349 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pilon, P. Dallaire, and A. Marette Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase: A NEW MECHANISM OF ACTION OF INSULIN-SENSITIZING DRUGS J. Biol. Chem., May 14, 2004; 279(20): 20767 - 20774. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, L. Groop, A. Nilsson, J. Weng, and T. Tuomi A Combination of Human Leukocyte Antigen DQB1*02 and the Tumor Necrosis Factor {alpha} Promoter G308A Polymorphism Predisposes to an Insulin-Deficient Phenotype in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2767 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Borge Jr. and B. A. Wolf Insulin Receptor Substrate 1 Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 3 in Insulin-secreting beta -Cells J. Biol. Chem., March 21, 2003; 278(13): 11359 - 11368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Barker, I. B. Leibiger, B. Leibiger, and P.-O. Berggren Phosphorylated inositol compounds in beta -cell stimulus-response coupling Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1113 - E1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J D Tugwood and C T Montague Biology and toxicology of PPARg ligands Human and Experimental Toxicology, August 1, 2002; 21(8): 429 - 437. [Abstract] [PDF] |
||||
![]() |
M. Aga, C. J. Johnson, A. P. Hart, A. G. Guadarrama, M. Suresh, J. Svaren, P. J. Bertics, and B. J. Darien Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7 J. Leukoc. Biol., July 1, 2002; 72(1): 222 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Hermann and N. Wiernsperger Impaired glucose tolerance and metformin: clinical and mechanistic aspects The British Journal of Diabetes & Vascular Disease, May 1, 2002; 2(3): 177 - 183. [Abstract] [PDF] |
||||
![]() |
H. Sugita, M. Kaneki, E. Tokunaga, M. Sugita, C. Koike, S. Yasuhara, R. G. Tompkins, and J. A. J. Martyn Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E386 - E394. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stefan, A. Fritsche, H. Häring, and M. Stumvoll Effect of Experimental Elevation of Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Healthy Carriers of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor-{gamma}2 Gene Diabetes, May 1, 2001; 50(5): 1143 - 1148. [Abstract] [Full Text] |
||||
![]() |
A. VON KNETHEN and B. BRUNE Delayed activation of PPAR{gamma} by LPS and IFN-{gamma} attenuates the oxidative burst in macrophages FASEB J, February 1, 2001; 15(2): 535 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Cruz, G. Kwon, C. A. Marshall, M. L. McDaniel, and C. F. Semenkovich Glucose and Insulin Stimulate Heparin-releasable Lipoprotein Lipase Activity in Mouse Islets and INS-1 Cells. A POTENTIAL LINK BETWEEN INSULIN RESISTANCE AND beta -CELL DYSFUNCTION J. Biol. Chem., April 6, 2001; 276(15): 12162 - 12168. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |